Macroeconomic factors, including interest rates and inflation, are beginning to improve, creating tailwinds for the substance use disorder (SUD) treatment industry. Lingering impacts of now-improving economic turbulence will continue to affect the industry, however. In turn, investors have had to become more disciplined, industry experts said at the Behavioral Health Business INVEST conference. Operators, meanwhile, […]
Lee Equity
The substance use disorder (SUD) treatment industry was formerly dotted by small, local providers. In the future, these mom-and-pop providers may go the way of cottage businesses during the Industrial Revolution. To be clear, SUD treatment has not yet been completely limited to assembly lines. Small providers still abound. At the recent Behavioral Health Business […]
Despite some public stumbles among private-equity-backed ABA providers, investors are still interested in the space. And 2024 could be a crucial M&A year for autism practices. This is partly because many ABA and autism providers completed their last transaction between 2017 and 2019. “As you think about the typical investment period, for those capital partners, […]
After a year of reckoning, the behavioral health industry is set up to see platform deals return to the market. In 2023, behavioral health dealmaking was down by roughly 30% year-over-year. This slowdown was partly due to macroeconomic trends, including inflation, high interest rates and the conflicts in Eastern Europe and the Middle East. The […]
Behavioral health operator Turnbridge is in talks to sell, touting about $15 million of EBITDA. Turnbridge, which provides mental health and substance use disorder (SUD) care, is pursuing a sale of the company, according to Axios. Investment banking firm Raymond James was hired to lead the sale, sources say. New Haven, Connecticut-based Turnbridge offers gender-specific […]